复发性肾细胞癌的综合全程管理策略：病例报告与文献综述
Comprehensive Whole-Course Management Strategy for Recurrent Renal Cell Carcinoma: Case Report and Literature Review.
作者信息
Hu PengNan, Chen Di, Yu Jun, Mi Hua
机构信息
Department of Urology The First Affiliated Hospital of Guangxi Medical University Nanning China.
出版信息
Clin Case Rep. 2025 May 1;13(5):e70418. doi: 10.1002/ccr3.70418. eCollection 2025 May.
Abstract
Renal cell carcinoma, a highly recurrent and metastatic malignancy. Drawing upon a decade-long expertise in managing recurrent cases, we advocate the adoption of Programmed Death-1 (PD-1) inhibitors in conjunction with Axitinib when monotherapy with Axitinib fails to restrain tumor metastasis, thereby empowering doctors with an efficacious treatment option.
摘要
肾细胞癌是一种具有高复发率和转移性的恶性肿瘤。凭借在处理复发病例方面长达十年的专业经验，我们主张在阿昔替尼单药治疗无法抑制肿瘤转移时，采用程序性死亡受体 1（PD-1）抑制剂联合阿昔替尼，从而为医生提供一种有效的治疗选择。
Zotero 插件